Commonwealth Equity Services’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-6,110
Closed -$1.06M 2286
2015
Q1
$1.06M Sell
6,110
-611
-9% -$89.7K 0.01% 918
2014
Q4
$773K Sell
6,721
-478
-7% -$57.9K 0.01% 1031
2014
Q3
$1.13M Sell
7,199
-19,218
-73% -$2.79M 0.01% 812
2014
Q2
$3.26M Buy
26,417
+18,859
+250% +$2.08M 0.04% 386
2014
Q1
$783K Buy
7,558
+567
+8% +$58.1K 0.01% 954
2013
Q4
$629K Sell
6,991
-176
-2% -$14K 0.01% 1017
2013
Q3
$479K Buy
7,167
+216
+3% +$14.9K 0.01% 1106
2013
Q2
$460K Buy
+6,951
New +$398K 0.01% 1058

Other funds holding SLXP

Commonwealth Equity Services's SLXP Position: Q2 2015 in Review

Commonwealth Equity Services sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 6,110 shares — an estimated $1.06M sold.

Commonwealth Equity Services first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $3.26M in Q2 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Commonwealth Equity Services reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Commonwealth Equity Services sold 6,110 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.06M.
  • Commonwealth Equity Services first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Commonwealth Equity Services's SALIX PHARMACEUTICALS LTD DEL position peaked at $3.26M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Commonwealth Equity Services's 13F filing for Q2 2015, filed 28 Jul 2015.